MiR-564 inhibits cancer cell proliferation, cell cycle progression, migration, and invasion.
miR-564 suppresses the tumorigenicity of lung cancer cell in vivo.
ZIC3 is a direct and functional target of miR-564.
The expression of miR-564 was negatively correlated with ZIC3 protein in tumors.
Both low miR-564 and high ZIC3 was associated with tumor stage and prognosis.